Suzhou Fushilai Pharmaceutical Co. Ltd. Net Asset Quality Index
Suzhou Fushilai Pharmaceutical Co. Ltd. net asset quality index. Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Net Asset Quality Index of 90.1% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.13 Billion minus total liabilities of CN¥211.52 Million yields net assets of CN¥1.92 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check earnings quality score of Suzhou Fushilai Pharmaceutical Co. Ltd. to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Net asset quality index of Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024. This chart shows how Suzhou Fushilai Pharmaceutical Co. Ltd.'s Net Asset Quality Index has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the index stands at 90.1%, representing net assets of CN¥1.92 Billion against total assets of CN¥2.13 Billion CNY. See Suzhou Fushilai Pharmaceutical Co. Ltd. book value and equity for net asset value and shareholders' equity analysis.
Suzhou Fushilai Pharmaceutical Co. Ltd. Net Asset Quality Index by Year (2019–2024)
Suzhou Fushilai Pharmaceutical Co. Ltd. net asset quality index by year from 2019 to 2024. The table below presents the year-by-year Net Asset Quality Index for Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Suzhou Fushilai Pharmaceutical Co. Ltd. market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 90.4% | CN¥1.89 Billion | CN¥2.09 Billion | CN¥200.84 Million | ▼ -1.6 pp |
| 2023 | 91.9% | CN¥1.95 Billion | CN¥2.12 Billion | CN¥170.45 Million | ▲ +2.0 pp |
| 2022 | 89.9% | CN¥1.89 Billion | CN¥2.10 Billion | CN¥211.75 Million | ▲ +13.4 pp |
| 2021 | 76.6% | CN¥742.84 Million | CN¥970.31 Million | CN¥227.47 Million | ▼ -2.4 pp |
| 2020 | 79.0% | CN¥622.64 Million | CN¥788.25 Million | CN¥165.61 Million | ▲ +1.5 pp |
| 2019 | 77.4% | CN¥581.96 Million | CN¥751.44 Million | CN¥169.48 Million | — |